Edwards Lifesciences Corporation today announced National Technology Park, Castletroy, Limerick, as the location of its new permanent facility which is expected to manufacture delivery components for its transcatheter heart valve therapies.
The global provider in patient-focused innovations for structural heart disease and critical care monitoring plans to complete this new, 170,000 square feet (approx.15,700 square meters) purpose-built manufacturing facility by 2021.
Once the facility is fully operational, the company expects it will employ approximately 600 people in roles ranging from leadership opportunities, planning, quality control, assembly, engineering and finance. Edwards’ investment in the project is expected to amount to approximately €80 million.
Over 60 people, production staff, engineering and professional management are expected to be employed at Edwards Lifesciences’ initial site in the Shannon Free Zone, which opened in August if this year.
Speaking today, Cllr James Collins, Mayor of Limerick City and County said, "Today’s announcement by Edwards Lifesciences is a huge endorsement of the Limerick city region and its ability to attract global leaders in the Life Sciences sector to set up here, it also further cements Limerick’s reputation as a go-to location for companies wishing to innovate and expand."
He added, "The eco-system in Limerick centered around co-operation between the local authority, state agencies and education providers has once again proven to be a winner for companies looking at investing in Ireland."